Ourania Tatsis $VRTX SEC Form 4 Insider Trading

Ourania Tatsis has filed a total of 57 insider trades in $VRTX since 2021. Their most recent trade was a sale of 260 shares, made on Feb 25, 2026. Their largest trade was a sale of 5,750 shares, made on Aug 10, 2023. We estimate that they now own 46,763 shares of $VRTX, worth an estimated $23.2 million.

Insider Trading at $VRTX

There have been a total of 561 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 2,437 shares reported by Duncan McKechnie (EVP, Chief Commercial Officer), made on Mar 04, 2026.

$VRTX Executives and Stock Owners with Insider Trades

• David Altshuler, EVP, Global Research and CSO

• Ourania Tatsis, EVP, Chief Reg. & Quality Off.

• Bastiano Sanna, EVP, Cell & Genetic Therapies

• Stuart A Arbuckle, EVP, COO

• Jeffrey M Leiden, Executive Chairman

• Charles F Jr Wagner, EVP & Chief Financial Officer

• Reshma Kewalramani, CEO & President

• Joy Liu, SVP, General Counsel

• Kristen Ambrose, SVP & Chief Accounting Officer

• Amit Sachdev, EVP Chief Patient & Ext Af Off

• Carmen Bozic, EVP and CMO

• Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.

• Jonathan Biller, EVP and Chief Legal Officer

• David Altshuler, EVP, Chief Scientific Officer

• Mark E. Bunnage, EVP, Chief Scientific Officer

• Amit Sachdev, EVP, Chief Patient Officer

• Duncan Mckechnie, EVP, Chief Commercial Officer

• Charles F Jr Wagner, EVP, CO & FO

• Joy Liu, EVP and Chief Legal Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.